Advertisement

Musk Says Neuralink to Begin Human Trials of Vision Chip

Immigration News

Fidel Rahmati
Fidel Rahmatihttps://www.khaama.com
Fidai Rahmati is the editor and content writer for Khaama Press. You may follow him at Twitter @FidelRahmati

Elon Musk says Neuralink plans to begin human implants of its experimental Blindsight brain chip within the next six to 12 months, with the technology aimed at restoring visual perception for people with severe vision loss. Neuralink lists the project as an upcoming clinical trial to investigate whether direct brain stimulation can help people “see without their eyes.”

The Blindsight device is designed to bypass damaged parts of the normal visual pathway by stimulating the brain’s visual cortex directly. Musk has previously said the technology has been tested in monkeys and could initially provide relatively low-resolution vision, with the possibility of improving over time.

Neuralink’s approach is based on a brain-computer interface in which implanted electrodes stimulate neurons involved in visual processing. The company says its planned study will focus on people with severe visual impairment, although human testing would be an early step toward determining whether the technology is safe and capable of producing useful visual perception.

Musk has made more ambitious claims about the technology, suggesting that future versions could allow people to perceive wavelengths outside the normal human visual range, including infrared and ultraviolet. Such capabilities, however, remain experimental possibilities rather than established medical outcomes.

The technology has received a Breakthrough Device designation from the U.S. Food and Drug Administration, a regulatory designation intended for certain medical devices addressing serious conditions. It does not mean that the device has been proven safe or effective.

Experts and previous reporting have highlighted the substantial challenges involved in translating brain-computer interface technology into reliable medical treatment. Researchers will need to assess surgical risks, the long-term stability of the implant and how effectively the brain can interpret artificially generated signals.

Neuralink has already conducted human trials of a different brain implant designed to help people with paralysis control external devices. Blindsight represents a more difficult application because it seeks to create a form of visual perception rather than simply decode brain signals to control a computer.

- Advertisement -

More articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here
Captcha verification failed!
CAPTCHA user score failed. Please contact us!

- Advertisement -spot_img

The World News